Acute and Chronic Heart Failure
The aim of this document is to provide practical, evidence-based guidelines for the diagnosis and treatment of heart failure (HF).
The principal changes from the 2008 guidelines relate to:
(i) an expansion of the indication for mineralocorticoid (aldosterone) receptor antagonists (MRAs);
(ii) a new indication for the sinus node inhibitor ivabradine;
(iii) an expanded indication for cardiac resynchronization therapy (CRT);
(iv) new information on the role of coronary revascularization in HF;
(v) recognition of the growing use of ventricular assist devices and
(vi) the emergence of transcatheter valve interventions.
There are also changes to the structure and format of the guidelines. Therapeutic recommendations now state the treatment effect supported by the class and level of recommendation in tabular format; in the case of chronic heart failure due to left ventricular (LV) systolic dysfunction, the recommendations focus on mortality and morbidity outcomes.
Guidelines er godkendt af DCS 10/1 2013. Hvor der er kommentarer, afvigende dansk tradition samt forslag til forbedringer, er bemærkningerne knyttet til et nummer og en sidehenvisning. Dette nummer genfindes på relevant plads i den engelsksprogede udgave af guidelines.
Hent godkendte guidelines inkl. danske kommentarer (3.24 MB)
